These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22944617)

  • 1. Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept.
    Wurch T; Pierré A; Depil S
    Trends Biotechnol; 2012 Nov; 30(11):575-82. PubMed ID: 22944617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel protein scaffolds as alternatives to whole antibodies for imaging and therapy: status on discovery research and clinical validation.
    Wurch T; Lowe P; Caussanel V; Bes C; Beck A; Corvaia N
    Curr Pharm Biotechnol; 2008 Dec; 9(6):502-9. PubMed ID: 19075688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro display technologies reveal novel biopharmaceutics.
    Rothe A; Hosse RJ; Power BE
    FASEB J; 2006 Aug; 20(10):1599-610. PubMed ID: 16873883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein engineering for therapeutics, Part A. Preface.
    Wittrup KD; Verdine GL
    Methods Enzymol; 2012; 502():xiii-xiv. PubMed ID: 22208991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protein scaffolds as alternatives to whole antibodies: from discovery research to clinical development].
    Wurch T; Lowe P; Beck A; Corvaia N
    Med Sci (Paris); 2009 Dec; 25(12):1169-72. PubMed ID: 20035700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered protein scaffolds as next-generation antibody therapeutics.
    Gebauer M; Skerra A
    Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
    Nygren PA
    FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.
    Huang C
    Curr Opin Biotechnol; 2009 Dec; 20(6):692-9. PubMed ID: 19889530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered affinity proteins--generation and applications.
    Grönwall C; Ståhl S
    J Biotechnol; 2009 Mar; 140(3-4):254-69. PubMed ID: 19428722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational and "irrational" design of proteins and their use in biotechnology.
    Nixon AE; Firestine SM
    IUBMB Life; 2000 Mar; 49(3):181-7. PubMed ID: 10868908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering antibodies for clinical applications.
    Jain M; Kamal N; Batra SK
    Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the realisation of lead-oriented synthesis.
    Doveston R; Marsden S; Nelson A
    Drug Discov Today; 2014 Jul; 19(7):813-9. PubMed ID: 24239725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered protein scaffolds for molecular recognition.
    Skerra A
    J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial chemistry in cancer drug development.
    Leonard KA; Deisseroth AB; Austin DJ
    Cancer J; 2001; 7(1):79-83. PubMed ID: 11269651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative non-antibody scaffolds for molecular recognition.
    Skerra A
    Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered proteins as specific binding reagents.
    Binz HK; Plückthun A
    Curr Opin Biotechnol; 2005 Aug; 16(4):459-69. PubMed ID: 16005204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant protein scaffolds for tissue engineering.
    Werkmeister JA; Ramshaw JA
    Biomed Mater; 2012 Feb; 7(1):012002. PubMed ID: 22262725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial, non-antibody binding proteins for pharmaceutical and industrial applications.
    Hey T; Fiedler E; Rudolph R; Fiedler M
    Trends Biotechnol; 2005 Oct; 23(10):514-22. PubMed ID: 16054718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When analoging is not enough: scaffold discovery in medicinal chemistry.
    Zhao H; Akritopoulou-Zanze I
    Expert Opin Drug Discov; 2010 Feb; 5(2):123-34. PubMed ID: 22822912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.